Search results for "Endometrial cancer"

showing 10 items of 94 documents

EPV139/#616 TP53 mutations differentially affect prognosis of endometrial cancer: an in-silico approach

2021

business.industryEndometrial cancerIn silicomedicineCancer researchTp53 mutationmedicine.diseaseAffect (psychology)businessE-Posters
researchProduct

Conservative Management of Atypical Endometrial Hyperplasia and Early Endometrial Cancer in Childbearing Age Women.

2022

Total hysterectomy and bilateral adnexectomy is the standard treatment for atypical endometrial hyperplasia and early-stage endometrial cancer. However, the recommended surgical treatment precludes future pregnancy when these conditions are diagnosed in women in their fertile age. In these patients, fertility-sparing treatment may be feasible if the desire for childbearing is consistent and specific conditions are present. This review summarizes the available evidence on fertility-sparing management for atypical endometrial hyperplasia and early-stage endometrial cancer. Historically, oral progestins have been the mainstay of conservative management for atypical endometrial hyperplasia and …

fertility-sparing treatmentFertility PreservationGeneral MedicineConservative TreatmentSettore MED/40 - Ginecologia E OstetriciaMetforminEndometrial NeoplasmsProgestinGonadotropin-Releasing HormoneTreatment OutcomeRetrospective StudiePregnancyendometrial cancerEndometrial HyperplasiaHumansEndometrial NeoplasmFemaleendometrial atypical hyperplasiaProgestinsHumanRetrospective StudiesMedicina (Kaunas, Lithuania)
researchProduct

Beyond Sentinel Lymph Node: Outcomes of Indocyanine Green-Guided Pelvic Lymphadenectomy in Endometrial and Cervical Cancer

2023

Background: The aim of our study was to compare the number of lymph nodes removed during indocyanine green (ICG)-guided laparoscopic/robotic pelvic lymphadenectomy with standard systematic lymphadenectomy in endometrial cancer (EC) and cervical cancer (CC). Methods: This is a multicenter retrospective comparative study (Clinical Trial ID: NCT04246580; updated on 31 January 2023). Women affected by EC and CC who underwent laparoscopic/robotic systematic pelvic lymphadenectomy, with (cases) or without (controls) the use of ICG tracer injection within the uterine cervix, were included in the study. Results: The two groups were homogeneous for age (p = 0.08), Body Mass Index, International Fede…

indocyanine greenRobotic surgery.pelvic lymphadenectomycervical cancerHealth Toxicology and Mutagenesisendometrial cancerrobotic surgeryPublic Health Environmental and Occupational Healthlaparoscopygynecologic oncologySettore MED/40 - Ginecologia E Ostetriciaminimally invasive surgerycervical cancer; endometrial cancer; gynecologic oncology; indocyanine green; laparoscopy; minimally invasive surgery; pelvic lymphadenectomy; robotic surgery
researchProduct

Nationwide Analysis on Surgical Staging Procedures and Systemic Treatment for Patients With Endometrial Cancer in Germany

2012

ObjectiveIn 2009 and 2006, the Arbeitsgemeinschaft Gynäkologische Onkologie evaluated therapeutic approaches for endometrial carcinoma (EC) in Germany.Methods and MaterialsA questionnaire was developed and sent to 775 German gynecologic departments in 2009 (500 in 2006). The results of the questionnaires were compared with each other and with the recommendations of the Arbeitsgemeinschaft Gynäkologische Onkologie’s guideline. Subgroup analyses were performed, dividing the participating centers into small and large centers and into centers with less and more experience with EC.ResultsResponses were available in 33.3% in 2009 and 35.8% in 2006. Comparing 2009 with 2006, it became apparent tha…

medicine.medical_specialtyGynecologic oncologySurgical stagingGynecologic Surgical ProceduresGermanySurveys and QuestionnairesCytologyAntineoplastic Combined Chemotherapy ProtocolsmedicineCarcinomaHumansMulticenter Studies as TopicPelvic lymphadenectomyDiagnostic Techniques Obstetrical and GynecologicalNeoplasm StagingGynecologybusiness.industryData CollectionGeneral surgeryEndometrial cancerObstetrics and GynecologyProfessional PracticeGuidelinemedicine.diseaseHospitalsPeritoneal washingEndometrial NeoplasmsOncologyLymph Node ExcisionFemaleGuideline AdherencebusinessCarcinoma EndometrioidInternational Journal of Gynecologic Cancer
researchProduct

8 A multicentric randomized trial to evaluate the role of uterine manipulator on laparoscopic/robotic hysterectomy for the treatment of low-risk endo…

2020

Background The role of the intrauterine manipulator in minimally invasive hysterectomy for endometrial cancer has been widely debated in terms of impact on the oncological outcomes. To date, definitive conclusions on the possible advantages and oncological safety of its use in endometrial cancer staging are still awaited. Objectives This randomized trial aimed to assess the role of the uterine manipulator in terms of oncological and perioperative outcomes in patients undergoing minimally invasive (laparoscopic/robotic) staging for presumed low-risk endometrial cancer. Study Design Enrolled patients were randomly allocated in two groups according to the use (Group A) or no use (Group B) of t…

medicine.medical_specialtyHysterectomybusiness.industrymedicine.medical_treatmentEndometrial cancerPerioperativemedicine.diseaseGroup BUterine manipulatorlaw.inventionSurgeryRobotic hysterectomyRandomized controlled triallawLaparotomymedicinebusinessOral Plenary
researchProduct

Robotic Hysterectomy in Severely Obese Patients With Endometrial Cancer: A Multicenter Study

2015

Abstract Study Objective The aim of this study was to evaluate the surgical and oncologic outcomes of robotic hysterectomy with or without or less pelvic and aortic lymphadenectomy in severely obese patients (body mass index [BMI] ≥ 40 kg/m 2 ) with endometrial cancer. Material and Methods Between August 2010 and November 2014, patients with histologically confirmed endometrial cancer and BMI ≥40 kg/m 2 were deemed eligible for the study and underwent RH with or without pelvic and aortic lymphadenectomy. Results Seventy patients were divided into 3 groups according to their BMI: group A, BMI between 40 and 45 kg/m 2 (50 patients); group B, BMI between 45 and 50 kg/m 2 (10 patients); and gro…

medicine.medical_specialtyIntraoperative Complicationmedicine.medical_treatmentHysterectomyBody Mass Index03 medical and health sciencesPostoperative Complications0302 clinical medicineRobotic Surgical ProceduresEndometrial cancerLaparotomymedicineHumansObesityRobotic hysterectomyMorbidIntraoperative ComplicationsLaparoscopyAged030219 obstetrics & reproductive medicineHysterectomymedicine.diagnostic_testbusiness.industryMedicine (all)Endometrial cancerObstetrics and GynecologyPostoperative complicationLength of StayMiddle Agedmedicine.diseaseEndometrial NeoplasmsObesity MorbidSurgerySettore MED/40 - GINECOLOGIA E OSTETRICIA030220 oncology & carcinogenesisLymph Node ExcisionFemaleLaparoscopyLymphadenectomyEndometrial cancer; Morbidity obese; Robotic hysterectomy; Aged; Body Mass Index; Endometrial Neoplasms; Female; Humans; Intraoperative Complications; Length of Stay; Lymph Node Excision; Middle Aged; Obesity Morbid; Postoperative Complications; Hysterectomy; Laparoscopy; Robotic Surgical Procedures; Obstetrics and Gynecology; Medicine (all)businessBody mass indexMorbidity obeseJournal of Minimally Invasive Gynecology
researchProduct

Synchronous Ovarian and Endometrial Cancer—an International Multicenter Case-Control Study

2013

ObjectivesThis study aimed to compare the prognosis of patients with synchronous endometrial and ovarian cancer (SEOC) to matched controls with either endometrial cancer (EC) or ovarian cancer (OC).MethodsA retrospective case-control study including all patients with SEOC who had been treated at 5 European tertiary gynecologic oncology centers between 1996 and 2011 and patients with either EC or OC matched for age, International Federation of Gynecology and Obstetrics (FIGO) stage, histology, year of diagnosis, and Eastern Cooperative Oncology Group performance score.ResultsThe study cohort comprised 77, 132, and 126 patients with SEOC, EC, and OC, respectively. The patient characteristics …

medicine.medical_specialtyMedizinGynecologic oncologyDisease-Free SurvivalCohort StudiesNeoplasms Multiple PrimaryTertiary Care CentersGermanymedicineHumansStage (cooking)Retrospective StudiesOvarian NeoplasmsGynecologybusiness.industryEndometrial cancerCarcinomaCase-control studyObstetrics and GynecologyRetrospective cohort studyMiddle Agedmedicine.diseaseEndometrial NeoplasmsOncologyCase-Control StudiesCohortFemalebusinessOvarian cancerCohort studyInternational Journal of Gynecologic Cancer
researchProduct

Obesity, an independent predictor of pre and postoperative tumor grading disagreement in endometrial cancer

2021

Abstract Introduction Obesity is a known independent risk factor for endometrial cancer (EC), and obese patients have a 4.7-fold increased risk compared to the general population to develop the neoplasm. To date, a general pre and postoperative tumor grading agreement from 53 % to 82 % is reported for endometrial analysis, and a consensus on which factors might influence the tumor grading discordance is still absent. Furthermore, although obesity alters the endometrial microenvironment, no studies investigated the role of obesity in the grading agreement of EC patients. This study aims to analyze the role of obesity in the pre and postoperative tumor grading agreement. Materials and methods…

medicine.medical_specialtyMultivariate analysisBiopsyConcordancePopulationGastroenterology03 medical and health sciences0302 clinical medicineInternal medicineTumor MicroenvironmentmedicineHumansObesity030212 general & internal medicineRisk factoreducationGrading (tumors)Retrospective Studieseducation.field_of_study030219 obstetrics & reproductive medicinebusiness.industryEndometrial cancerObstetrics and GynecologyCancerOdds ratiomedicine.diseaseEndometrial NeoplasmsReproductive MedicineFemaleNeoplasm GradingbusinessEuropean Journal of Obstetrics & Gynecology and Reproductive Biology
researchProduct

Prognostische Bedeutung einer Diabeteserkrankung beim Endometriumkarzinom

2001

Objective: The purposes of this study were to analyze the relationship between clinical and pathological risk factors in endometrial cancer and additional diabetes mellitus and to clarify the correlation between additional diabetes mellitus and survival of patients with this disease. - Material and methods: This analyze included 181 patients with endometrial carcinoma who were treated between 1985 and 1995 at the University hospital Mainz. Patients with sarcoma were excluded. For statistical analysis a Χ 2 -test was performed for univariat analysis. A Kaplan-Meier procedure was performed for over all survival and disease free interval and COX-Regression for multivariate analysis of independ…

medicine.medical_specialtyMultivariate analysisbusiness.industryEndometrial cancerObstetrics and GynecologyDiseasemedicine.diseaseGastroenterologyMetastasisSurgeryInternal medicineDiabetes mellitusmedicineCarcinomaSarcomabusinessPathologicalZentralblatt für Gynäkologie
researchProduct

246 Survival of elderly patients with endometrial cancer – predicted by preoperative G-8 geriatric screening tool

2021

Introduction/Background* We evaluated the prognostic impact of various global health assessment tools in accordance to conventional prognostic factors in patients with endometrial cancer (EC) older than 60 years. Methodology G-8 geriatric screening tool (G-8 geriatric score), Lee Schonberg prognostic index (Lee-Index), Charlson Comorbidity Index (CCI) and American Society of Anesthesiologists (ASA-PS) – Physical Status System were retrospectively determined in a consecutive cohort of elderly patients with EC. Univariate and multivariate Cox regression analyses and Kaplan-Meier method were performed to determine the impact of the global health assessment tools on progression free survival (P…

medicine.medical_specialtyMultivariate statisticsMultivariate analysisbusiness.industryProportional hazards modelEndometrial cancerUnivariatemedicine.diseaseInternal medicineCohortMedicineProgression-free survivalbusinessGrading (tumors)Endometrial cancer
researchProduct